DalsnaFinance

Lifecore Biomedical Inc $LFCR

Health Care

Russell 2000 Minnesota
Create a scorecard
$6.37
+0.00 (0.00%)
As of Oct 22, 2026, 9:30 PM EDT
Price history
Loading chart…

Lifecore Biomedical Inc (LFCR) is trading up at $6.37 (0.00%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.

Lifecore Biomedical Inc revenue & net income history (FY2016–FY2025)

RevenueNet incomeNet margin (right axis, %)
$557.6M$220.4M−$116.7MFY2016 revenue: $541.1MFY2016 net income: −$11.6M · Net margin −2.2%'16FY2017 revenue: $532.3MFY2017 net income: $10.6M · Net margin 2.0%'17FY2018 revenue: $524.2MFY2018 net income: $24.8M · Net margin 4.7%'18FY2019 revenue: $557.6MFY2019 net income: $411.0K · Net margin 0.1%'19FY2020 revenue: $160.1MFY2020 net income: −$38.2M · Net margin −23.9%'20FY2021 revenue: $100.9MFY2021 net income: −$32.3M · Net margin −32.0%'21FY2022 revenue: $111.3MFY2022 net income: −$116.7M · Net margin −104.9%'22FY2023 revenue: $103.3MFY2023 net income: −$99.6M · Net margin −96.4%'23FY2024 revenue: $128.3MFY2024 net income: $12.0M · Net margin 9.4%'24FY2025 revenue: $128.9MFY2025 net income: −$38.7M · Net margin −30.0%'25−4.2%0%5%10%15%20%FY2016 net margin: −2.2%FY2017 net margin: 2.0%FY2018 net margin: 4.7%FY2019 net margin: 0.1%FY2020 net margin: −23.9% (off the scale, which stops at −4.2%)FY2021 net margin: −32.0% (off the scale, which stops at −4.2%)FY2022 net margin: −104.9% (off the scale, which stops at −4.2%)FY2023 net margin: −96.4% (off the scale, which stops at −4.2%)FY2024 net margin: 9.4%FY2025 net margin: −30.0% (off the scale, which stops at −4.2%)
Lifecore Biomedical Inc annual financial statements
FY2016May 2016FY2017May 2017FY2018May 2018FY2019May 2019FY2020May 2020FY2021May 2021FY2022May 2022FY2023May 2023FY2024May 2024FY2025May 2025
Income statement
Revenue$541.1M$532.3M$524.2M$557.6M$160.1M$100.9M$111.3M$103.3M$128.3M$128.9M
Growth (year over year)+0.3%−1.6%−1.5%+6.4%−71.3%−37.0%+10.3%−7.2%+24.2%+0.5%
Gross profit$66.8M$79.2M$78.3M$81.0M$39.4M$38.9M$39.1M$28.0M$41.9M$40.3M
Gross margin12.3%14.9%14.9%14.5%24.6%38.6%35.1%27.1%32.6%31.3%
Operating income−$20.6M$14.7M$13.6M$5.47M−$25.9M−$8.82M−$11.8M−$21.8M−$8.84M−$17.2M
Operating margin−3.8%2.8%2.6%1.0%−16.2%−8.7%−10.6%−21.1%−6.9%−13.4%
Net income−$11.6M$10.6M$24.8M$411.0K−$38.2M−$32.3M−$116.7M−$99.6M$12.0M−$38.7M
Net margin−2.2%2.0%4.7%0.1%−23.9%−32.0%−104.9%−96.4%9.4%−30.0%
EPS (diluted)−$0.43$0.38$0.89$0.01−$1.31−$1.10−$3.97−$3.32$0.33−$1.27
Balance sheet
Cash and equivalents$9.97M$6.00M$2.90M$1.08M$360.0K$763.0K$991.0K$19.1M$8.46M$8.27M
Total assets$342.7M$358.6M$404.7M$519.1M$293.5M$501.9M$274.7M$253.5M$254.0M$239.3M
Total liabilities$130.3M$130.5M$152.1M$248.9M$310.3M$299.9M$186.9M$218.5M$200.1M$191.9M
Long-term debt$46.0M$42.3M$37.4M$87.2M$101.4M$164.9M$0$84.3M$100.8M$130.4M
Shareholders' equity$210.7M$226.6M$252.6M$270.1M$229.8M$201.9M$87.8M−$4.23M$11.3M$1.34M
Cash flow
Operating cash flow$20.8M$29.8M$19.8M$16.0M−$17.0M$16.5M−$22.6M−$17.4M$257.0K−$206.0K
Capital expenditure$39.7M$23.0M$33.6M$44.7M$12.2M$19.3M$26.2M—$18.4M$13.4M
Free cash flow−$18.9M$6.83M−$13.8M−$28.7M−$29.3M−$2.79M−$48.8M—−$18.1M−$13.6M

From Lifecore Biomedical Inc's 10-K, 10-KT and 10-Q filings with the SEC; its fiscal year ends in May. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

About Lifecore Biomedical Inc

Headquarters
Chaska, Minnesota From SEC filings, Oct 2026

Recent News (2)

More Health Care stocks

Browse all companies →